Zacks Investment Research cut shares of National Health Investors, Inc. (NYSE:NHI) from a buy rating to a hold rating in a report published on Friday.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
A number of other analysts also recently weighed in on NHI. Stifel Nicolaus reiterated a buy rating and set a $82.00 target price on shares of National Health Investors in a research report on Wednesday, October 4th. ValuEngine upgraded National Health Investors from a hold rating to a buy rating in a research report on Friday, November 10th. Capital One Financial Corporation initiated coverage on National Health Investors in a research report on Monday, October 23rd. They set an equal weight rating for the company. BMO Capital Markets reiterated a hold rating and set a $80.00 target price on shares of National Health Investors in a research report on Wednesday, October 18th. Finally, SunTrust Banks, Inc. initiated coverage on National Health Investors in a research report on Tuesday, October 10th. They set a hold rating and a $80.00 target price for the company. One research analyst has rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $80.14.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2017/11/20/zacks-investment-research-lowers-national-health-investors-inc-nhi-to-hold.html.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be given a dividend of $0.95 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $3.80 annualized dividend and a dividend yield of 4.88%. National Health Investors’s dividend payout ratio is currently 95.00%.
In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares in the company, valued at approximately $1,693,994.40. The sale was disclosed in a filing with the SEC, which is available through this link. 5.19% of the stock is owned by corporate insiders.
Several hedge funds have recently made changes to their positions in NHI. BlackRock Inc. lifted its position in shares of National Health Investors by 6.6% during the 2nd quarter. BlackRock Inc. now owns 3,547,049 shares of the real estate investment trust’s stock worth $280,927,000 after buying an additional 218,482 shares during the last quarter. Allianz Asset Management GmbH lifted its position in shares of National Health Investors by 57.8% during the 3rd quarter. Allianz Asset Management GmbH now owns 394,800 shares of the real estate investment trust’s stock worth $30,514,000 after buying an additional 144,650 shares during the last quarter. State Street Corp increased its holdings in National Health Investors by 8.5% in the 2nd quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock worth $79,133,000 after purchasing an additional 78,355 shares in the last quarter. Vanguard Group Inc. increased its holdings in National Health Investors by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 6,291,954 shares of the real estate investment trust’s stock worth $498,323,000 after purchasing an additional 72,518 shares in the last quarter. Finally, Renaissance Technologies LLC acquired a new position in National Health Investors in the 1st quarter worth about $4,796,000. Institutional investors and hedge funds own 68.08% of the company’s stock.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about National Health Investors Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for National Health Investors Inc. and related companies.